In situ gel-forming dual drug delivery system for synergistic combination therapy of colorectal peritoneal carcinomatosis

RSC Advances

Volumn 5, Issue 123, 2015, Pages 101494-101506

  Li, Xiaoling ^a   Fan, Rangrang ^a   Wang, Yuelong ^a   Wu, Min ^a   Tong, Aiping ^a   Shi, Juan ^b   Xiang, Mingli ^a   Zhou, Liangxue ^a   Guo, Gang ^a  

^a SICHUAN UNIVERSITY   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCK COPOLYMERS; CELL DEATH; CELL PROLIFERATION; CHEMOTHERAPY; CROSSLINKING; DIAGNOSIS; DIALYSIS MEMBRANES; DISEASES; DRUG PRODUCTS; DRUG THERAPY; HYDROGELS; MICELLES; PATIENT TREATMENT; SOLS; SURGERY; TUMORS;

BIODEGRADABLE COPOLYMERS; CONTROLLED DRUG DELIVERY SYSTEMS; CYTOTOXICITY IN VITRO; PERITONEAL CARCINOMATOSIS; PHYSIOLOGICAL TEMPERATURE; SUSTAINED DRUG RELEASE; SYNERGISTIC COMBINATIONS; THERMOSENSITIVE POLYMER HYDROGELS;

CONTROLLED DRUG DELIVERY;

EID: 84948654746     PISSN: None     EISSN: 20462069     Source Type: Journal    
DOI: 10.1039/c5ra21067d     Document Type: Article

References (46)

1. R. Siegel C. Desantis A. Jemal Colorectal Cancer statistics Ca-Cancer J. Clin. 2014 64 104 117
2. O. Glehen F. Kwiatkowski P. H. Sugarbaker D. Elias E. A. Levine M. de Simone R. Barone Y. Yonemura F. Cavaliere F. Quenet M. Gutman A. A. Tentes G. Lorimier J. L. Bernard J. M. Bereder J. Porcheron A. Gomez-Portilla P. Shen M. Deraco P. Rat Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study J. Clin. Oncol. 2004 22 3284 3292
3. J. Franko Q. Shi C. D. Goldman B. A. Pockaj G. D. Nelson R. M. Goldberg H. C. Pitot A. Grothey S. R. Alberts D. J. Sargent Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841 J. Clin. Oncol. 2012 30 263 267
4. A. L. Bloemendaal V. J. Verwaal S. van Ruth H. Boot F. A. Zoetmulder Conventional surgery and systemic chemotherapy for peritoneal carcinomatosis of colorectal origin: a prospective study Eur. J. Surg. Oncol. 2005 31 1145 1151
5. R. F. Ozols M. A. Bookman R. C. Young Intraperitoneal chemotherapy for ovarian cancer N. Engl. J. Med. 2006 354 1641 1643
6. D. Elias E. Benizri D. Di Pietrantonio P. Menegon D. Malka B. Raynard Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis Ann. Surg. Oncol. 2007 14 509 514
7. R. de Souza P. Zahedi E. N. Moriyama C. J. Allen B. C. Wilson M. Piquette-Miller Continuous docetaxel chemotherapy improves therapeutic efficacy in murine models of ovarian cancer Mol. Cancer Ther. 2010 9 1820 1830
8. P. Zahedi R. de Souza M. Piquette-Miller C. J. Allen Chitosan-phospholipid blend for sustained and localized delivery of docetaxel to the peritoneal cavity Int. J. Pharm. 2009 377 76 84
9. A. S. Crystal A. T. Shaw L. V. Sequist L. Friboulet M. J. Niederst E. L. Lockerman R. L. Frias J. F. Gainor A. Amzallag P. Greninger D. Lee A. Kalsy M. Gomez-Caraballo L. Elamine E. Howe W. Hur E. Lifshits H. E. Robinson R. Katayama A. C. Faber M. M. Awad S. Ramaswamy M. Mino-Kenudson A. J. Iafrate C. H. Benes J. A. Engelman Patient-derived models of acquired resistance can identify effective drug combinations for cancer Science 2014 346 1480 1486
10. J. Lehar A. S. Krueger W. Avery A. M. Heilbut L. M. Johansen E. R. Price R. J. Rickles G. F. Short III J. E. Staunton X. Jin M. S. Lee G. R. Zimmermann A. A. Borisy Synergistic drug combinations tend to improve therapeutically relevant selectivity Nat. Biotechnol. 2009 27 659 666
11. I. Bozic J. G. Reiter B. Allen T. Antal K. Chatterjee P. Shah Y. S. Moon A. Yaqubie N. Kelly D. T. Le E. J. Lipson P. B. Chapman L. A. Diaz B. Vogelstein M. A. Nowak Evolutionary dynamics of cancer in response to targeted combination therapy eLife 2013 2 e00747
12. A. Anitha M. Sreeranganathan K. P. Chennazhi V. K. Lakshmanan R. Jayakumar In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies Eur. J. Pharm. Biopharm. 2014 88 238 251
13. J. M. Munson L. Fried S. A. Rowson M. Y. Bonner L. Karumbaiah B. Diaz S. A. Courtneidge U. G. Knaus D. J. Brat J. L. Arbiser R. V. Bellamkonda Anti-Invasive Adjuvant Therapy with Imipramine Blue Enhances Chemotherapeutic Efficacy Against Glioma Sci. Transl. Med. 2012 4 127
14. M. J. McConnell P. M. Herst Ascorbate combination therapy: New tool in the anticancer toolbox Sci. Transl. Med. 2014 6 222
15. L. D. Mayer T. O. Harasym P. G. Tardi N. L. Harasym C. R. Shew S. A. Johnstone E. C. Ramsay M. B. Bally A. S. Janoff Ratiometric dosing of anticancer drug combinations: Controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice Mol. Cancer Ther. 2006 5 1854 1863
16. C. Poon C. He D. Liu K. Lu W. Lin Self-assembled nanoscale coordination polymers carrying oxaliplatin and gemcitabine for synergistic combination therapy of pancreatic cancer J. Controlled Release 2015 201 90 99
17. H. Xiao W. Li R. Qi L. Yan R. Wang S. Liu Y. Zheng Z. Xie Y. Huang X. Jing Co-delivery of daunomycin and oxaliplatin by biodegradable polymers for safer and more efficacious combination therapy J. Controlled Release 2012 163 304 314
18. R. R. Fan Y. L. Wang B. Han Y. B. Luo L. X. Zhou X. R. Peng M. Wu Y. Zheng G. Guo Docetaxel load biodegradable porous microspheres for the treatment of colorectal peritoneal carcinomatosis Int. J. Biol. Macromol. 2014 69 100 107
19. L. Ostacolo M. Marra F. Ungaro S. Zappavigna G. Maglio F. Quaglia A. Abbruzzese M. Caraglia In vitro anticancer activity of docetaxel-loaded micelles based on poly(ethylene oxide)-poly(epsilon-caprolactone) block copolymers: Do nanocarrier properties have a role? J. Controlled Release 2010 148 255 263
20. G. Guo S. Z. Fu L. X. Zhou H. Liang M. Fan F. Luo Z. Y. Qian Y. Q. Wei Preparation of curcumin loaded poly (ε-caprolactone)-poly (ethylene glycol)-poly (ε-caprolactone) nanofibers and their in vitro antitumor activity against Glioma 9L cells Nanoscale 2011 3 3825 3832
21. B. Jeong Y. H. Bae D. S. Lee S. W. Kim Biodegradable block copolymers as injectable drug-delivery systems Nature 1997 388 860 862
22. D. Seliktar Designing Cell-Compatible Hydrogels for Biomedical Applications Science 2012 336 1124 1128
23. L. Yu J. Ding Injectable hydrogels as unique biomedical materials Chem. Soc. Rev. 2008 37 1473 1481
24. R. L. Huang W. Qi L. B. Feng R. X. Su Z. M. He Self-assembling peptide-polysaccharide hybrid hydrogel as a potential carrier for drug delivery Soft Matter 2011 7 6222 6230
25. C. He S. W. Kim D. S. Lee In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery J. Controlled Release 2008 127 189 207
26. S. C. Owen D. P. Y. Chan M. S. Shoichet Polymeric micelle stability Nano Today 2012 7 53 65
27. X. Zhang X. Zeng X. Liang Y. Yang X. Li H. Chen L. Huang L. Mei S. S. Feng The chemotherapeutic potential of PEG-b-PLGA copolymer micelles that combine chloroquine as autophagy inhibitor and docetaxel as an anti-cancer drug Biomaterials 2014 35 9144 9154
28. C. Deng Y. J. Jiang R. Cheng F. H. Meng Z. Y. Zhong Biodegradable polymeric micelles for targeted and controlled anticancer drug delivery: promises, progress and prospects Nano Today 2012 7 467 480
29. X. Gao S. Wang B. Wang S. Deng X. Liu X. Zhang L. Luo R. Fan M. Xiang C. You Y. Wei Z. Qian G. Guo Improving the anti-ovarian cancer activity of docetaxel with biodegradable self-assembly micelles through various evaluations Biomaterials 2015 53 646 658
30. J. Hrkach D. von Hoff M. Mukkaram E. Andrianova J. Auer T. Campbell D. de Witt M. Figa M. Figueiredo A. Horhota S. Low K. McDonnell E. Peeke B. Retnarajan A. Sabnis E. Schnipper J. J. Song Y. H. Song J. Summa D. Tompsett G. Troiano T. van Geen Hoven J. Wright P. LoRusso P. W. Kantoff N. H. Bander C. Sweeney O. C. Farokhzad R. Langer S. Zale Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile Sci. Transl. Med. 2012 4 128
31. A. Stein D. Arnold Oxaliplatin: a review of approved uses Expert Opin. Pharmacother. 2012 13 125 137
32. S. Iqbal H. J. Lenz D. R. Gandara S. I. Shibata S. Groshen T. W. Synold E. M. Newman A phase I trial of oxaliplatin in combination with docetaxel in patients with advanced solid tumors Cancer Chemother. Pharmacol. 2013 72 85 91
33. A. Atmaca S. E. Al-Batran D. Werner C. Pauligk T. Güner A. Koepke H. Bernhard T. Wenzel A. G. Banat P. Brueck K. Caca N. Prasnikar F. Kullmann H. Günther Derigs M. Koenigsmann G. Dingeldein T. Neuhaus E. A. Jäger A randomised multicentre phase II study with cisplatin/docetaxel vs. oxaliplatin/docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancer Br. J. Cancer 2013 108 265 270
34. C. Barone M. Basso G. Schinzari C. Pozzo N. Trigila E. D'Argento M. Quirino A. Astone A. Cassano Docetaxel and oxaliplatin combination in second-line treatment of patients with advanced gastric cancer Gastric Cancer 2007 10 104 111
35. C. Yang H. Z. Liu Z. X. Fu W. D. Lu Oxaliplatin long-circulating liposomes improved therapeutic index of colorectal carcinoma BMC Biotechnol. 2011 11 21 29
36. H. J. Moon D. Y. Ko M. H. Park M. K. Joo B. Jeong Temperature-responsive compounds as in situ gelling biomedical materials Chem. Soc. Rev. 2012 41 4860 4883
37. M. K. Joo M. H. Park B. G. Choi B. Jeong Reverse thermogelling biodegradable polymer aqueous solutions J. Mater. Chem. 2009 19 5891 5905
38. Y. Yang J. C. Wang X. Zhang W. Lu Q. Zhang A novel mixed micelle gel with thermo-sensitive property for the local delivery of docetaxel J. Controlled Release 2009 135 175 182
39. T. Y. Ci L. Chen L. Yu J. D. Ding Tumor regression achieved by encapsulating a moderately soluble drug into a polymeric thermogel Sci. Rep. 2014 4 5473
40. K. Li L. Yu X. J. Liu C. Chen Q. H. Chen J. D. Ding A long-acting formulation of a polypeptide drug exenatide in treatment of diabetes using an injectable block copolymer hydrogel Biomaterials 2013 34 2834 2842
41. H. J. Chung Y. Le T. G. Park Thermo-sensitive and biodegradable hydrogels based on stereocomplexed Pluronic multi-block copolymers for controlled protein delivery J. Controlled Release 2008 127 22 30
42. J. Zhai M. H. Tracey J. W. Lynne F. Celesta T. Nhiem M. Xavier J. D. Calum W. M. Benjamin Lipid-PEG conjugates sterically stabilize and reduce the toxicity of phytantriol-based lyotropic liquid crystalline nanoparticles Langmuir 2015 31 10871 10880
43. X. J. Loh Y. X. Tan Z. Li L. S. Teo S. H. Goh J. Li Biodegradable thermogelling poly(ester urethane)s consisting of poly(lactic acid) - Thermodynamics of micellization and hydrolytic degradation Biomaterials 2008 29 2164 2172
44. E. L. Schwartz Antivascular actions of microtubule-binding drugs Clin. Cancer Res. 2009 15 2594 2601
45. F. Ungaro C. Conte L. Ostacolo G. Maglio A. Barbieri C. Arra G. Misso A. Abbruzzese M. Caraglia F. Quaglia Core-shell biodegradable nanoassemblies for the passive targeting of docetaxel: features, antiproliferative activity and in vivo toxicity Nanomedicine 2012 8 637 646
46. L. Li B. Ahmed K. Mehta R. Kurzrock Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer Mol. Cancer Ther. 2007 6 1276 1282